Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

61 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Determinants of immunosuppressive therapy in renal transplant recipients: an Italian observational study (the CESIT project).
Rosa AC, Finocchietti M, Agabiti N, Menè P, Bracaccia ME, Bellini A, Massari M, Spila Alegiani S, Masiero L, Bedeschi G, Cardillo M, Lucenteforte E, Piccolo G, Leoni O, Ferroni E, Pierobon S, Nordio M, Ledda S, Garau D, Davoli M, Addis A, Belleudi V; CESIT study group. Rosa AC, et al. Among authors: spila alegiani s. BMC Nephrol. 2023 Oct 27;24(1):320. doi: 10.1186/s12882-023-03325-9. BMC Nephrol. 2023. PMID: 37891504 Free PMC article.
Patterns and trends of utilization of incretin-based medicines between 2008 and 2014 in three Italian geographic areas.
Roberto G, Barone-Adesi F, Giorgianni F, Pizzimenti V, Ferrajolo C, Tari M, Bartolini C, Da Cas R, Maggini M, Spila-Alegiani S, Francesconi P, Trifirò G, Poluzzi E, Baccetti F, Gini R. Roberto G, et al. Among authors: spila alegiani s. BMC Endocr Disord. 2019 Feb 7;19(1):18. doi: 10.1186/s12902-019-0334-y. BMC Endocr Disord. 2019. PMID: 30732592 Free PMC article.
Broad Spectrum project: factors determining the quality of antibiotic use in primary care: an observational study protocol from Italy.
Kurotschka PK, Serafini A, Massari M, Da Cas R, Figueiras A, Forte V, Moro MF, Massidda M, Contu F, Minerba L, Marcias M, Nardelli M, Perra A, Carta MG, Spila Alegiani S. Kurotschka PK, et al. Among authors: spila alegiani s. BMJ Open. 2020 Jul 6;10(7):e038843. doi: 10.1136/bmjopen-2020-038843. BMJ Open. 2020. PMID: 32636291 Free PMC article.
Renin-Angiotensin-Aldosterone System Inhibitors and Risk of Death in Patients Hospitalised with COVID-19: A Retrospective Italian Cohort Study of 43,000 Patients.
Trifirò G, Massari M, Da Cas R, Menniti Ippolito F, Sultana J, Crisafulli S, Giorgi Rossi P, Marino M, Zorzi M, Bovo E, Leoni O, Ludergnani M, Spila Alegiani S; ITA-COVID-19: RAAS inhibitor group. Trifirò G, et al. Among authors: spila alegiani s. Drug Saf. 2020 Dec;43(12):1297-1308. doi: 10.1007/s40264-020-00994-5. Drug Saf. 2020. PMID: 32852721 Free PMC article.
Survival of Hospitalized COVID-19 Patients in Northern Italy: A Population-Based Cohort Study by the ITA-COVID-19 Network.
Ferroni E, Giorgi Rossi P, Spila Alegiani S, Trifirò G, Pitter G, Leoni O, Cereda D, Marino M, Pellizzari M, Fabiani M, Riccardo F, Sultana J, Massari M; ITA-COVID Working Group. Ferroni E, et al. Among authors: spila alegiani s. Clin Epidemiol. 2020 Dec 8;12:1337-1346. doi: 10.2147/CLEP.S271763. eCollection 2020. Clin Epidemiol. 2020. PMID: 33335428 Free PMC article.
Risk of coronavirus disease 2019 hospitalization and mortality in rheumatic patients treated with hydroxychloroquine or other conventional disease-modifying anti-rheumatic drugs in Italy.
Spila Alegiani S, Crisafulli S, Giorgi Rossi P, Mancuso P, Salvarani C, Atzeni F, Gini R, Kirchmayer U, Belleudi V, Kurotschka PK, Leoni O, Ludergnani M, Ferroni E, Baracco S, Massari M, Trifirò G; ITA-COVID-19 Network. Spila Alegiani S, et al. Rheumatology (Oxford). 2021 Oct 9;60(SI):SI25-SI36. doi: 10.1093/rheumatology/keab348. Rheumatology (Oxford). 2021. PMID: 33856453 Free PMC article.
Association of Influenza Vaccination and Prognosis in Patients Testing Positive to SARS-CoV-2 Swab Test: A Large-Scale Italian Multi-Database Cohort Study.
Massari M, Spila-Alegiani S, Fabiani M, Belleudi V, Trifirò G, Kirchmayer U, Poggi FR, Mancuso P, Menniti-Ippolito F, Gini R, Bartolini C, Leoni O, Ercolanoni M, Da-Re F, Guzzinati S, Luxi N, Riccardo F, Giorgi-Rossi P. Massari M, et al. Among authors: spila alegiani s. Vaccines (Basel). 2021 Jul 1;9(7):716. doi: 10.3390/vaccines9070716. Vaccines (Basel). 2021. PMID: 34358133 Free PMC article.
Large-Scale Postmarketing Surveillance of Biological Drugs for Immune-Mediated Inflammatory Diseases Through an Italian Distributed Multi-Database Healthcare Network: The VALORE Project.
Trifirò G, Isgrò V, Ingrasciotta Y, Ientile V, L'Abbate L, Foti SS, Belleudi V, Poggi F, Fontana A, Moretti U, Lora R, Sabaini A, Senesi I, Sorrentino C, Puzo MR, Padula A, Fusco M, Giordana R, Solfrini V, Puccini A, Rossi P, Del Zotto S, Leoni O, Zanforlini M, Ancona D, Bavaro V, Garau D, Ledda S, Scondotto S, Allotta A, Tuccori M, Gini R, Bucaneve G, Franchini D, Cavazzana A, Biasi V, Spila Alegiani S, Massari M; VALORE Project Collaborators. Trifirò G, et al. Among authors: spila alegiani s. BioDrugs. 2021 Nov;35(6):749-764. doi: 10.1007/s40259-021-00498-3. Epub 2021 Oct 12. BioDrugs. 2021. PMID: 34637126 Free PMC article.
Time to Treatment Intensification in Patients Receiving DPP4 Inhibitors Versus Sulfonylureas as the First Add-On to Metformin Monotherapy: A Retrospective Cohort Study.
Roberto G, Girardi A, Barone-Adesi F, Pecere A, Ientile V, Bartolini C, Da Cas R, Spila-Alegiani S, Ferrajolo C, Francesconi P, Trifirò G, Poluzzi E, Baccetti F, Gini R. Roberto G, et al. Among authors: spila alegiani s. Front Pharmacol. 2022 May 30;13:871052. doi: 10.3389/fphar.2022.871052. eCollection 2022. Front Pharmacol. 2022. PMID: 35707398 Free PMC article.
61 results